应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
AGIO Agios Pharmaceuticals, Inc.
盘前交易 12-23 05:58:41 EST
35.42
-0.39
-1.09%
盘前
35.22
-0.20
-0.56%
05:54 EST
最高
36.30
最低
35.13
成交量
319.91万
今开
35.50
昨收
35.81
日振幅
3.27%
总市值
20.20亿
流通市值
17.89亿
总股本
5,703万
成交额
1.14亿
换手率
6.33%
流通股本
5,052万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Agios Pharmaceuticals, Inc.盘中异动 快速下跌5.10%
市场透视 · 12-19
Agios Pharmaceuticals, Inc.盘中异动 快速下跌5.10%
Agios Pharmaceuticals, Inc.盘中异动 股价大跌5.08%报39.83美元
市场透视 · 12-19
Agios Pharmaceuticals, Inc.盘中异动 股价大跌5.08%报39.83美元
Agios Pharmaceuticals, Inc.盘中异动 急速拉升5.20%报40.99美元
市场透视 · 12-16
Agios Pharmaceuticals, Inc.盘中异动 急速拉升5.20%报40.99美元
Agios Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.00%
市场透视 · 12-12
Agios Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.00%
Agios Pharmaceuticals, Inc.盘中异动 大幅拉升5.20%
市场透视 · 12-10
Agios Pharmaceuticals, Inc.盘中异动 大幅拉升5.20%
Agios Pharmaceuticals, Inc.盘中异动 早盘大幅下挫8.97%报56.11美元
市场透视 · 12-09
Agios Pharmaceuticals, Inc.盘中异动 早盘大幅下挫8.97%报56.11美元
Agios Pharmaceuticals, Inc.盘中异动 股价大涨5.03%
市场透视 · 12-05
Agios Pharmaceuticals, Inc.盘中异动 股价大涨5.03%
Agios Pharmaceuticals, Inc.2024财年第三财季实现净利润9.48亿美元,同比增加1138.11%
市场透视 · 11-09
Agios Pharmaceuticals, Inc.2024财年第三财季实现净利润9.48亿美元,同比增加1138.11%
Agios Pharmaceuticals, Inc.盘中异动 股价大涨5.17%
市场透视 · 11-06
Agios Pharmaceuticals, Inc.盘中异动 股价大涨5.17%
Agios 制药公司公布截至 1 月 1 日的季度业绩 - 收益摘要
Reuters · 11-01
Agios 制药公司公布截至 1 月 1 日的季度业绩 - 收益摘要
Agios Pharmaceuticals, Inc.盘中异动 急速下跌5.59%
市场透视 · 10-31
Agios Pharmaceuticals, Inc.盘中异动 急速下跌5.59%
Agios Pharmaceuticals, Inc.盘中异动 下午盘快速上涨5.02%
市场透视 · 10-17
Agios Pharmaceuticals, Inc.盘中异动 下午盘快速上涨5.02%
Agios Pharmaceuticals, Inc.盘中异动 股价大跌6.66%
市场透视 · 09-27
Agios Pharmaceuticals, Inc.盘中异动 股价大跌6.66%
BUZZ--美国股票走势-木薯科学公司、波浪生命科学公司、班布尔公司
Reuters · 09-27
BUZZ--美国股票走势-木薯科学公司、波浪生命科学公司、班布尔公司
BUZZ-Leerink 表示,Agios 的药物可能与辉瑞的镰状细胞治疗效果相似
Reuters · 09-27
BUZZ-Leerink 表示,Agios 的药物可能与辉瑞的镰状细胞治疗效果相似
BUZZ--美国股票走势-Crocs、First Solar、高通公司
Reuters · 09-27
BUZZ--美国股票走势-Crocs、First Solar、高通公司
BUZZ-辉瑞撤出镰状细胞药物后,镰状细胞药物开发商数量增加
Reuters · 09-26
BUZZ-辉瑞撤出镰状细胞药物后,镰状细胞药物开发商数量增加
Agios Pharmaceuticals, Inc.盘中异动 股价大涨5.01%
市场透视 · 09-26
Agios Pharmaceuticals, Inc.盘中异动 股价大涨5.01%
Agios Pharmaceuticals, Inc.2024财年第二财季实现净利润-96.12百万美元,同比减少14.69%
自选股智能写手 · 08-10
Agios Pharmaceuticals, Inc.2024财年第二财季实现净利润-96.12百万美元,同比减少14.69%
Agios Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.57%报44.98美元
自选股智能写手 · 08-07
Agios Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.57%报44.98美元
暂无数据
公司概况
公司名称:
Agios Pharmaceuticals, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Agios Pharmaceuticals, Inc.于2007年8月7日在特拉华州注册成立。该公司是一家生物制药公司,致力于通过细胞代谢领域的领导地位改变患者的生活,目标是为罕见病创造差异化药物,重点是经典血液学。
发行价格:
--
{"stockData":{"symbol":"AGIO","market":"US","secType":"STK","nameCN":"Agios Pharmaceuticals, Inc.","latestPrice":35.42,"timestamp":1734728400000,"preClose":35.81,"halted":0,"volume":3199144,"hourTrading":{"tag":"盘前","latestPrice":35.22,"preClose":35.42,"latestTime":"05:54 EST","volume":240,"amount":8589.57,"timestamp":1734951295304},"delay":0,"floatShares":50522137,"shares":57030195,"eps":11.798295,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.39,"latestTime":"12-23 05:58:41 EST","open":35.5,"high":36.3,"low":35.13,"amount":113605784.721208,"amplitude":0.032672,"askPrice":40,"askSize":100,"bidPrice":32.14,"bidSize":100,"shortable":3,"etf":0,"ttmEps":11.798295,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734964200000},"adr":0,"listingDate":1374638400000,"adjPreClose":35.42,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":35.22,"preClose":35.42,"latestTime":"05:54 EST","volume":240,"amount":8589.57,"timestamp":1734951295304},"postHourTrading":{"tag":"盘后","latestPrice":35.42,"preClose":35.42,"latestTime":"17:55 EST","volume":1659209,"amount":58769183.587,"timestamp":1734735304940},"volumeRatio":2.7073963515259756,"impliedVol":0.6477,"impliedVolPercentile":0.856},"requestUrl":"/m/hq/s/AGIO/tweets","defaultTab":"tweets","newsList":[{"id":"2492917084","title":"Agios Pharmaceuticals, Inc.盘中异动 快速下跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492917084","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492917084?lang=zh_cn&edition=full","pubTime":"2024-12-19 23:34","pubTimestamp":1734622474,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日23时34分,Agios Pharmaceuticals, Inc.股票出现异动,股价大幅跳水5.10%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为1.83%。其相关个股中,Nls Pharmaceutics Ltd C/Wts 02/02/2026、Abpro Holdings Inc C/Wts 12/11/2029 、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大,Psyence Biomedical Ltd.、Elevai Labs, Inc.、Phio Pharmaceuticals Corp.较为活跃,换手率分别为829.19%、533.42%、455.34%,振幅较大的相关个股有Sab Biotherapeutics Inc C/Wts 22/10/2026 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ,振幅分别为166.50%、96.43%、63.91%。Agios Pharmaceuticals, Inc.公司简介:Agios Pharmaceuticals Inc 是一家生物制药公司,专注于开发针对癌症和罕见遗传代谢疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219233434984cdab4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219233434984cdab4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AGIO","BK4139"],"gpt_icon":0},{"id":"2492153161","title":"Agios Pharmaceuticals, Inc.盘中异动 股价大跌5.08%报39.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492153161","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492153161?lang=zh_cn&edition=full","pubTime":"2024-12-19 03:54","pubTimestamp":1734551695,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日03时54分,Agios Pharmaceuticals, Inc.股票出现异动,股价急速跳水5.08%。截至发稿,该股报39.83美元/股,成交量46.3816万股,换手率0.81%,振幅5.86%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为1.95%。Agios Pharmaceuticals, Inc.公司简介:Agios Pharmaceuticals Inc 是一家生物制药公司,专注于开发针对癌症和罕见遗传代谢疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219035456984cb774&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219035456984cb774&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AGIO","BK4139"],"gpt_icon":0},{"id":"2491690553","title":"Agios Pharmaceuticals, Inc.盘中异动 急速拉升5.20%报40.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491690553","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491690553?lang=zh_cn&edition=full","pubTime":"2024-12-16 22:58","pubTimestamp":1734361085,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日22时58分,Agios Pharmaceuticals, Inc.股票出现异动,股价急速拉升5.20%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.69%。其相关个股中,Viridian Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大,Tonix Pharmaceuticals Holding Corp.、Dermata Therapeutics, Inc.、Genprex, Inc.较为活跃,换手率分别为54.34%、33.34%、32.24%,振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts To Pur Com、Estrella Immunopharma, Inc.、Briacell Therapeutics Corp C/Wts 24/02/2025,振幅分别为46.67%、23.46%、22.09%。Agios Pharmaceuticals, Inc.公司简介:Agios Pharmaceuticals Inc 是一家生物制药公司,专注于开发针对癌症和罕见遗传代谢疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216225805ab7ca11d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216225805ab7ca11d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AGIO","BK4139"],"gpt_icon":0},{"id":"2490534894","title":"Agios Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490534894","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490534894?lang=zh_cn&edition=full","pubTime":"2024-12-12 03:22","pubTimestamp":1733944978,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日03时22分,Agios Pharmaceuticals, Inc.股票出现波动,股价大幅下挫5.00%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.24%。Agios Pharmaceuticals, Inc.公司简介:Agios Pharmaceuticals Inc 是一家生物制药公司,专注于开发针对癌症和罕见遗传代谢疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212032258a1e6f249&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212032258a1e6f249&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AGIO","BK4139"],"gpt_icon":0},{"id":"2490014513","title":"Agios Pharmaceuticals, Inc.盘中异动 大幅拉升5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490014513","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490014513?lang=zh_cn&edition=full","pubTime":"2024-12-10 22:49","pubTimestamp":1733842160,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日22时49分,Agios Pharmaceuticals, Inc.股票出现波动,股价快速上涨5.20%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为1.07%。其相关个股中,Chimerix, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Uniqure N.V.涨幅较大,Psyence Biomedical Ltd.、Processa Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃,换手率分别为1837.51%、421.60%、97.59%,振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Chimerix, Inc.、Uniqure N.V.,振幅分别为131.78%、83.23%、33.45%。Agios Pharmaceuticals, Inc.公司简介:Agios Pharmaceuticals Inc 是一家生物制药公司,专注于开发针对癌症和罕见遗传代谢疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210224920984b0cdc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210224920984b0cdc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AGIO"],"gpt_icon":0},{"id":"2490773291","title":"Agios Pharmaceuticals, Inc.盘中异动 早盘大幅下挫8.97%报56.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490773291","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490773291?lang=zh_cn&edition=full","pubTime":"2024-12-09 22:30","pubTimestamp":1733754634,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日22时30分,Agios Pharmaceuticals, Inc.股票出现波动,股价快速下跌8.97%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。其相关个股中,Sonnet Biotherapeutics Holdings, Inc.、Metagenomi, Inc.、Celularity Inc C/Wts 16/07/2026 涨幅较大,Sonnet Biotherapeutics Holdings, Inc.、Dermata Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃,换手率分别为2035.00%、22.50%、18.51%,振幅较大的相关个股有Tnf Pharmaceuticals, Inc.、Unity Biotechnology, Inc.、Allogene Therapeutics, Inc.,振幅分别为108.26%、101.68%、101.37%。Agios Pharmaceuticals, Inc.公司简介:Agios Pharmaceuticals Inc 是一家生物制药公司,专注于开发针对癌症和罕见遗传代谢疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209223035ab6a08fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209223035ab6a08fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AGIO"],"gpt_icon":0},{"id":"2489162041","title":"Agios Pharmaceuticals, Inc.盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489162041","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489162041?lang=zh_cn&edition=full","pubTime":"2024-12-05 00:13","pubTimestamp":1733328802,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日00时13分,Agios Pharmaceuticals, Inc.股票出现波动,股价大幅上涨5.03%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.30%。其相关个股中,Cyclerion Therapeutics, Inc.、Exicure, Inc.、Heron Therapeutics, Inc.涨幅较大,Cyclerion Therapeutics, Inc.、Can Fite Biopharma Ltd、Windtree Therapeutics, Inc.较为活跃,换手率分别为3108.70%、246.07%、128.28%,振幅较大的相关个股有Cyclerion Therapeutics, Inc.、Apollomics Inc C/Wts 01/04/2028 、Eterna Therapeutics Inc.,振幅分别为237.89%、61.31%、55.22%。Agios Pharmaceuticals, Inc.公司简介:Agios Pharmaceuticals Inc 是一家生物制药公司,专注于开发针对癌症和罕见遗传代谢疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205001322abf5f950&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205001322abf5f950&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AGIO","BK4139"],"gpt_icon":0},{"id":"2482485628","title":"Agios Pharmaceuticals, Inc.2024财年第三财季实现净利润9.48亿美元,同比增加1138.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482485628","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482485628?lang=zh_cn&edition=full","pubTime":"2024-11-09 00:00","pubTimestamp":1731081627,"startTime":"0","endTime":"0","summary":"11月9日,Agios Pharmaceuticals, Inc.公布财报,公告显示公司2024财年第三财季净利润为9.48亿美元,同比增加1138.11%;其中营业收入为8.96百万美元,同比增加21.08%,每股基本收益为16.65美元。机构评级:截至2024年11月9日,当前有8家机构对Agios Pharmaceuticals, Inc.目标价做出预测,其中目标均价为53.88美元,其中最低目标价为46.00美元,最高目标价为57.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109000140abae6eba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109000140abae6eba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AGIO"],"gpt_icon":0},{"id":"2481983311","title":"Agios Pharmaceuticals, Inc.盘中异动 股价大涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481983311","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481983311?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:39","pubTimestamp":1730903967,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时39分,Agios Pharmaceuticals, Inc.股票出现异动,股价急速上涨5.17%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.21%。其相关个股中,Sonnet Biotherapeutics Holdings, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大,Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃,换手率分别为1070.77%、125.67%、59.29%,振幅较大的相关个股有Lakeshore Biopharma Co., Ltd、Inmed Pharmaceuticals Inc.、Uniqure N.V.,振幅分别为107.44%、106.04%、105.12%。Agios Pharmaceuticals, Inc.公司简介:Agios Pharmaceuticals Inc 是一家生物制药公司,专注于开发针对癌症和罕见遗传代谢疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223927a21d2f34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223927a21d2f34&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AGIO"],"gpt_icon":0},{"id":"2480092045","title":"Agios 制药公司公布截至 1 月 1 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2480092045","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480092045?lang=zh_cn&edition=full","pubTime":"2024-11-01 11:32","pubTimestamp":1730431966,"startTime":"0","endTime":"0","summary":" * Agios Pharmaceuticals Inc 报告,截至1月1日的季度调整后每股亏损2.42美元,低于去年同期的每股收益1.64美元。十位分析师对该季度的平均预期为每股收益 1.11 美元。华尔街预期为每股收益 1.85 美元至 12.42 美元。* Agios Pharmaceuticals Inc公布的本季度每股收益为16.22美元。* 该公司报告的季度净收入为 9.4792 亿美元。* Agios Pharmaceuticals Inc 的股价本季度上涨了 4.2%,今年迄今为止上涨了 107.9%。华尔街对 Agios Pharmaceuticals Inc 的 12 个月目标价中位数为 56.00 美元。本摘要由 LSEG 数据于 11 月 1 日 03:32 a.m. UTC 机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Agios 制药公司公布截至 1 月 1 日的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIO","BK4139"],"gpt_icon":0},{"id":"2479925080","title":"Agios Pharmaceuticals, Inc.盘中异动 急速下跌5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479925080","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479925080?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:33","pubTimestamp":1730381603,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时33分,Agios Pharmaceuticals, Inc.股票出现波动,股价急速跳水5.59%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为1.74%。其相关个股中,Aerovate Therapeutics, Inc.、Engene Holdings Inc C/Wts 31/10/2028 Cl A、180 Life Sciences Corp C/Wts 07/11/2025涨幅较大,Evogene Ltd.、Aditxt, Inc.、Palisade Bio, Inc.较为活跃,换手率分别为194.20%、186.73%、146.01%,振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Equillium, Inc.、Evogene Ltd.,振幅分别为21.98%、14.49%、12.08%。Agios Pharmaceuticals, Inc.公司简介:Agios Pharmaceuticals Inc 是一家生物制药公司,专注于开发针对癌症和罕见遗传代谢疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031213323a2020ea6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031213323a2020ea6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AGIO"],"gpt_icon":0},{"id":"2476183925","title":"Agios Pharmaceuticals, Inc.盘中异动 下午盘快速上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476183925","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476183925?lang=zh_cn&edition=full","pubTime":"2024-10-17 02:14","pubTimestamp":1729102477,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日02时14分,Agios Pharmaceuticals, Inc.股票出现异动,股价急速上涨5.02%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.11%。其相关个股中,180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025、Korro Bio, Inc.涨幅较大,180 Life Sciences Corp.、Quoin Pharmaceuticals Ltd、Biodexa Pharmaceuticals Plc较为活跃,换手率分别为7731.39%、1982.14%、1176.28%,振幅较大的相关个股有180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025、Quoin Pharmaceuticals Ltd,振幅分别为633.55%、279.52%、198.41%。Agios Pharmaceuticals, Inc.公司简介:Agios Pharmaceuticals Inc 是一家生物制药公司,专注于开发针对癌症和罕见遗传代谢疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017021438ab6a971d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017021438ab6a971d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AGIO"],"gpt_icon":0},{"id":"2470869420","title":"Agios Pharmaceuticals, Inc.盘中异动 股价大跌6.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470869420","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470869420?lang=zh_cn&edition=full","pubTime":"2024-09-27 21:32","pubTimestamp":1727443973,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日21时32分,Agios Pharmaceuticals, Inc.股票出现波动,股价快速下挫6.66%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.48%。其相关个股中,Pasithea Therapeutics Corp C/Wts 12/08/2026 、Onconetix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大,Onconetix, Inc.、Cardio Diagnostics Holdings Inc.、Seelos Therapeutics, Inc.较为活跃,换手率分别为1972.95%、61.47%、50.07%,振幅较大的相关个股有Traws Pharma, Inc.、Tonix Pharmaceuticals Holding Corp.、Pasithea Therapeutics Corp.,振幅分别为11.80%、11.57%、11.28%。Agios Pharmaceuticals, Inc.公司简介:Agios Pharmaceuticals Inc 是一家生物制药公司,专注于开发针对癌症和罕见遗传代谢疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409272132539581e323&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409272132539581e323&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AGIO"],"gpt_icon":0},{"id":"2470856190","title":"BUZZ--美国股票走势-木薯科学公司、波浪生命科学公司、班布尔公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2470856190","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470856190?lang=zh_cn&edition=full","pubTime":"2024-09-27 21:25","pubTimestamp":1727443525,"startTime":"0","endTime":"0","summary":"美东时间9:06,道指电子盘 上涨0.15%,报42,618 点。标普500指数 上涨0.16%,报5813.5点;纳斯达克100指数 上涨0.19%,报20384点。纽约证交所盘前涨幅前两位的股票 :** Nine Energy Service, Inc ,上涨12.5%** IonQ, Inc ,上涨10.8%纽交所盘前跌幅前三名 :** Methode Electronics, Inc ,下跌6.9%** MeridianLink, Inc ,下跌6%** OneConnect Financial Technology ,下跌6.2%纳斯达克盘前涨幅前两位的股票 :** Onconetix, Inc ,上涨87.2%** CN Energy Group Inc ,上涨77. 6%** Bristol Myers Squibb Co :盘前上涨 3.6%BUZZ - 因 FDA 批准其精神分裂症药物而上涨 ** 阿里巴巴集团 盘前上涨1.1%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0328353924.USD","LU0823039010.USD","LU1674673428.USD","LU1674673691.USD","WVE","LU2095319765.USD","BK4581","LOW","LU1803068979.SGD","LU1162221912.USD","L","BK4588","LU2210150020.SGD","BMBL","BMY","IE0034235188.USD","ESTA","LU1064131342.USD","PGY","HD","CRM","IONQ","CPB","LU0327786744.USD","LU0225284248.USD","LU1316542783.SGD","LU2360106947.USD","LU0047713382.USD","COST","BK4509","LU2210149790.SGD","BK4501","BK4503","BK4579","BK4585","LU1496350502.SGD","KMX","AGIO","LU0642271901.SGD","LU1046421795.USD","DG","IE0009355771.USD","LU0149725797.USD","LU0187121727.USD","FDN","SAVA","LU0823038988.USD","LU0314104364.USD"],"gpt_icon":1},{"id":"2470170192","title":"BUZZ-Leerink 表示,Agios 的药物可能与辉瑞的镰状细胞治疗效果相似","url":"https://stock-news.laohu8.com/highlight/detail?id=2470170192","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470170192?lang=zh_cn&edition=full","pubTime":"2024-09-27 19:31","pubTimestamp":1727436703,"startTime":"0","endTime":"0","summary":" 9月27日 - ** 经纪公司Leerink称,Agios制药公司的 实验性药物mitapivat可能与辉瑞公司的 镰状细胞病治疗药物Oxbryta具有类似的生理效应。** 周三,辉瑞公司从所有获批市场上撤回了 Oxbryta,理由是该药有可能引发痛苦的并发症和死亡。** Leerink分析师安德鲁-贝伦斯说,如果正在进行的mitapivat晚期试验取得成功,撤出Oxbryta对Agios来说可能是一个机会。** 然而,Berens表示,与辉瑞的药物结果类似的风险可能仍然是Agios股价的一个悬念。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFE","SG9999003800.SGD","AGIO","BK4533","LU1057294990.SGD","IE00B19Z3581.USD","LU0289739699.SGD","BK4588","LU1066053197.SGD","IE00B19Z3B42.SGD","IE00BBT3K403.USD","LU0225284248.USD","SG9999001176.SGD","SG9999002224.SGD","LU0456855351.SGD","LU1894683348.USD","BK4139","IE0002270589.USD","LU0058720904.USD","BK4592","LU1894683264.USD","BK4550","SG9999002232.USD","BK4007","LU0170899867.USD","IE000M9KFDE8.USD","LU0985481810.HKD","LU1066051498.USD","SG9999011175.SGD","BK4581","LU0234572021.USD","BK4568","LU0122379950.USD","BK4585","LU0306806265.USD","LU0225771236.USD","SGXZ57979304.SGD","LU0868494617.USD","BK4534","LU1883839398.USD","LU0321505439.SGD","SG9999013999.USD","LU0306807586.USD","LU0321505868.SGD","SG9999001176.USD","IE00BLSP4452.SGD","IE00BLSP4239.USD","LU1023059063.AUD"],"gpt_icon":1},{"id":"2470517007","title":"BUZZ--美国股票走势-Crocs、First Solar、高通公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2470517007","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470517007?lang=zh_cn&edition=full","pubTime":"2024-09-27 00:14","pubTimestamp":1727367247,"startTime":"0","endTime":"0","summary":" * Eikon 个股走势搜索字符串:[STXBZ] * The Day Ahead 新闻通讯: * The Morning News Call时事通讯: 9月26日 - 华尔街主要股指周四上涨,标普500指数创下历史新高,原因是美光公司的乐观预测重燃了人工智能热潮,而一份申请失业救济人数低于预期的报告舒缓了人们对劳动力市场的担忧。美东时间11:38,道琼斯工业平均指数 上涨0.5%,至42135.45点。标普500指数 上涨0.22%,报5,734.93 点;纳斯达克综合指数 上涨0.23%,报18,124.285点。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"19d76ac8a99e856ca115d767258d984a","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EOG","TQQQ","CDE","XOM","2NVD.UK","WVE","QCOM","COP","CLNE","DOG","3NVD.UK","AGIO","CROX","MRVL","SONO","KMX","LNG",".DJI","TLN","RRC","HAL","JEF","CVX","L","FULC","FANG","SHOT","SNX","DJX","WMB","UAA",".IXIC",".SPX","CNX","NQmain","UDOW","DDM"],"gpt_icon":1},{"id":"2470573006","title":"BUZZ-辉瑞撤出镰状细胞药物后,镰状细胞药物开发商数量增加","url":"https://stock-news.laohu8.com/highlight/detail?id=2470573006","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470573006?lang=zh_cn&edition=full","pubTime":"2024-09-26 22:36","pubTimestamp":1727361370,"startTime":"0","endTime":"0","summary":" 9月26日 - ** Agios Pharmaceuticals 股价上涨~3%,报50.29美元;Fulcrum Therapeutics 上涨~20%,报4.15美元 ** 较大的竞争对手辉瑞 从所有获批市场撤出其镰状细胞病药物Oxbryta, ,理由是该药物有引发痛苦的并发症和死亡的风险。** 镰状细胞病是一种遗传性血液疾病,会影响红细胞中的血红蛋白** 分析师预计,该药的退出将有助于促进竞争对手镰状细胞病药物的试验注册。** Leerink Partners的分析师称,Oxbryta的退出可能会对FULC早期研究的入组产生积极影响,尤其是正在或曾经单独服用Oxbryta的患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"31475a2f05bb5a0cf2e7acfeae2c0e13","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066053197.SGD","BK4588","IE00BBT3K403.USD","LU0225771236.USD","BK4581","LU0058720904.USD","PFE","BK4550","LU1894683348.USD","SG9999002232.USD","BK4568","LU0170899867.USD","LU1883839398.USD","IE00BLSP4239.USD","LU0122379950.USD","SG9999003800.SGD","SG9999002224.SGD","LU0321505439.SGD","SGXZ57979304.SGD","BK4007","BK4533","SG9999001176.SGD","BK4139","IE0002270589.USD","LU1894683264.USD","SG9999011175.SGD","LU0868494617.USD","BK4585","LU1023059063.AUD","LU1066051498.USD","LU0306806265.USD","LU0306807586.USD","LU0985481810.HKD","SG9999001176.USD","LU1057294990.SGD","BK4592","IE000M9KFDE8.USD","IE00BLSP4452.SGD","LU0321505868.SGD","FULC","LU0225284248.USD","LU0234572021.USD","AGIO","IE00B19Z3581.USD","SG9999013999.USD","IE00B19Z3B42.SGD","LU0456855351.SGD","BK4534","LU0289739699.SGD"],"gpt_icon":1},{"id":"2470297965","title":"Agios Pharmaceuticals, Inc.盘中异动 股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470297965","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470297965?lang=zh_cn&edition=full","pubTime":"2024-09-26 03:26","pubTimestamp":1727292414,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日03时26分,Agios Pharmaceuticals, Inc.股票出现异动,股价大幅拉升5.01%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.55%。其相关个股中,Pasithea Therapeutics Corp C/Wts 12/08/2026 、Surrozen Inc C/Wts 01/08/2031 、Transcode Therapeutics, Inc.涨幅较大,Seelos Therapeutics, Inc.、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃,换手率分别为384.86%、230.24%、179.83%,振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Cero Therapeutics Holdings, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028,振幅分别为107.20%、88.58%、70.69%。Agios Pharmaceuticals, Inc.公司简介:Agios Pharmaceuticals Inc 是一家生物制药公司,专注于开发针对癌症和罕见遗传代谢疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926032654a1dc8240&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240926032654a1dc8240&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AGIO","BK4139"],"gpt_icon":0},{"id":"2458477515","title":"Agios Pharmaceuticals, Inc.2024财年第二财季实现净利润-96.12百万美元,同比减少14.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458477515","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458477515?lang=zh_cn&edition=full","pubTime":"2024-08-10 00:17","pubTimestamp":1723220224,"startTime":"0","endTime":"0","summary":"8月10日,Agios Pharmaceuticals, Inc.公布财报,公告显示公司2024财年第二财季净利润为-96.12百万美元,同比减少14.69%;其中营业收入为8.62百万美元,同比增加28.46%,每股基本收益为-1.69美元。机构评级:截至2024年8月10日,当前有6家机构对Agios Pharmaceuticals, Inc.目标价做出预测,其中目标均价为54.33美元,其中最低目标价为46.00美元,最高目标价为60.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408100017159f1e0ff5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408100017159f1e0ff5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AGIO"],"gpt_icon":0},{"id":"2457384940","title":"Agios Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.57%报44.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457384940","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457384940?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:32","pubTimestamp":1723037553,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日21时32分,Agios Pharmaceuticals, Inc.股票出现异动,股价大幅拉升5.57%。截至发稿,该股报44.98美元/股,成交量1.4353万股,换手率0.03%,振幅2.58%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.59%。Agios Pharmaceuticals, Inc.公司简介:Agios Pharmaceuticals Inc 是一家生物制药公司,专注于开发针对癌症和罕见遗传代谢疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408072132379f1774ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408072132379f1774ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AGIO","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.agios.com","stockEarnings":[{"period":"1week","weight":-0.091},{"period":"1month","weight":-0.3515},{"period":"3month","weight":-0.2391},{"period":"6month","weight":-0.2167},{"period":"1year","weight":0.5488},{"period":"ytd","weight":0.5905}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Agios Pharmaceuticals, Inc.于2007年8月7日在特拉华州注册成立。该公司是一家生物制药公司,致力于通过细胞代谢领域的领导地位改变患者的生活,目标是为罕见病创造差异化药物,重点是经典血液学。","yearOnYearQuotes":[{"month":1,"riseRate":0.818182,"avgChangeRate":0.042769},{"month":2,"riseRate":0.636364,"avgChangeRate":0.059258},{"month":3,"riseRate":0.545455,"avgChangeRate":0.003251},{"month":4,"riseRate":0.545455,"avgChangeRate":0.006144},{"month":5,"riseRate":0.545455,"avgChangeRate":0.049654},{"month":6,"riseRate":0.636364,"avgChangeRate":0.046688},{"month":7,"riseRate":0.363636,"avgChangeRate":-0.024214},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.046002},{"month":9,"riseRate":0.5,"avgChangeRate":0.041136},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.014099},{"month":11,"riseRate":0.666667,"avgChangeRate":0.063175},{"month":12,"riseRate":0.416667,"avgChangeRate":-0.046395}],"exchange":"NASDAQ","name":"Agios Pharmaceuticals, Inc.","nameEN":"Agios Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Agios Pharmaceuticals, Inc.(AGIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Agios Pharmaceuticals, Inc.(AGIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Agios Pharmaceuticals, Inc.,AGIO,Agios Pharmaceuticals, Inc.股票,Agios Pharmaceuticals, Inc.股票老虎,Agios Pharmaceuticals, Inc.股票老虎国际,Agios Pharmaceuticals, Inc.行情,Agios Pharmaceuticals, Inc.股票行情,Agios Pharmaceuticals, Inc.股价,Agios Pharmaceuticals, Inc.股市,Agios Pharmaceuticals, Inc.股票价格,Agios Pharmaceuticals, Inc.股票交易,Agios Pharmaceuticals, Inc.股票购买,Agios Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Agios Pharmaceuticals, Inc.(AGIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Agios Pharmaceuticals, Inc.(AGIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}